gemcitabine has been researched along with Kidney Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, R; Etani, T; Hamamoto, S; Iida, K; Kawai, N; Nagai, T; Naiki, T; Nozaki, S; Sugiyama, Y; Tasaki, Y; Yasui, T | 1 |
| Furukawa, M; Furuse, J; Ikeda, M; Ishii, H; Iwai, T; Kamata, K; Katanuma, A; Kataoka, T; Kato, N; Kawamoto, Y; Kojima, Y; Miyakawa, H; Miyamoto, A; Mizuno, N; Mizusawa, J; Morizane, C; Nakagohri, T; Nishina, T; Okano, N; Okusaka, T; Oono, T; Ozaka, M; Sano, K; Shimizu, K; Shimizu, S; Shioji, K; Shirakawa, H; Sudo, K; Sugimori, K; Takahashi, H; Tobimatsu, K; Todaka, A; Ueno, M; Yamaguchi, H; Yamamoto, T; Yamashita, T; Yasuda, I | 1 |
| Belaiche, S; Couraud, S; Moro-Sibilot, D; Sakhri, L; Toffart, AC | 1 |
| Deray, G; Isnard-Bagnis, C; Janus, N; Karie, S; Launay-Vacher, V | 1 |
| Arima, K; Hasegawa, Y; Kise, H; Nishikawa, K; Soga, N; Sugimura, Y; Yamada, Y | 1 |
| Baudrin, L; Belmont, L; Cadranel, J; Danel, S; Epaud, C; Gounant, V; Lavolé, A; Milleron, B; Rosencher, L; Ruppert, AM | 1 |
| Bellmunt, J; Carles, J; Gallén, M; Guix, M; Morales-Barrera, R; Serrano, C; Suárez, C; Valverde, C | 1 |
| Ashimine, S; Kimura, R; Machida, N; Matsumura, E; Miyagi, R; Miyazato, M; Oshiro, Y; Saito, S | 1 |
| Bajorin, DF; Boyle, MG; Galsky, MD; Iasonos, A; Mironov, S; Scattergood, J | 1 |
| Anderson, H; Lund, B; Martin, C; Thatcher, N | 1 |
| Gietema, JA; Groen, HJ; Meijer, S; Smit, EF | 1 |
| Carles, J; Domènech, M; Guasch, I; Ibeas, R; Nogué, M; Pérez, C; Saigí, E; Villadiego, K | 1 |
2 review(s) available for gemcitabine and Kidney Diseases
| Article | Year |
|---|---|
[Impact of lung cancer treatments on renal function].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Deoxycytidine; Diphosphonates; Gemcitabine; Glutamates; Guanine; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Lung Neoplasms; Pemetrexed | 2014 |
Gemcitabine: once-weekly schedule active and better tolerated than twice-weekly schedule.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Kidney Diseases; Lung Neoplasms; Neoplasms; Thrombocytopenia | 1996 |
5 trial(s) available for gemcitabine and Kidney Diseases
| Article | Year |
|---|---|
Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Biomarkers; Deoxycytidine; Disease Management; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Kidney Diseases; Kidney Function Tests; Male; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Treatment Outcome | 2021 |
Gemcitabine and capecitabine chemotherapy in Japanese patients with immunotherapy-resistant renal cell carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Renal Cell; Deoxycytidine; Drug Therapy, Combination; Female; Fluorouracil; Gemcitabine; Humans; Japan; Kidney Diseases; Male; Middle Aged; Neoplasm Metastasis; Treatment Outcome | 2009 |
Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Kidney Diseases; Male; Middle Aged; Urinary Bladder Neoplasms | 2012 |
Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Gemcitabine; Humans; Kidney Diseases; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Survival Rate; Urinary Bladder Neoplasms | 2007 |
Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Female; Gemcitabine; Humans; Kidney Diseases; Male; Middle Aged; Survival Analysis; Urinary Bladder Neoplasms | 2000 |
5 other study(ies) available for gemcitabine and Kidney Diseases
| Article | Year |
|---|---|
Efficacy of a Newly Modified Short Hydration Method for Gemcitabine and Cisplatin Combination Chemotherapy in Patients with Urothelial Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Creatinine; Deoxycytidine; Female; Fluid Therapy; Gemcitabine; Humans; Hyponatremia; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Sodium; Urinary Bladder Neoplasms; Urologic Neoplasms | 2020 |
[Chemotherapy and renal toxicity].
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carboplatin; Carmustine; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Kidney; Kidney Diseases; Lomustine; Methotrexate; Organoplatinum Compounds; Oxaliplatin | 2008 |
Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Creatinine; Deoxycytidine; Docetaxel; Etoposide; Female; Fluid Therapy; Gemcitabine; Humans; Kidney; Kidney Diseases; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Small Cell Lung Carcinoma; Taxoids; Vinblastine; Vinorelbine | 2012 |
[A case of renal salt wasting syndrome progressing to severe hyponatremia after gemcitabine-cisplatin chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Diagnosis, Differential; Gemcitabine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Diseases; Male; Sodium; Urinary Bladder Neoplasms | 2012 |
Effects of gemcitabine on renal function in patients with non-small cell lung cancer.
Topics: Adult; Aged; Albuminuria; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Erythrocytes; Female; Gemcitabine; Glomerular Filtration Rate; Humans; Kidney Diseases; Lung Neoplasms; Male; Middle Aged; Renal Plasma Flow, Effective | 1998 |